Company research / LFCR

LIFECORE BIOMEDICAL, INC. DE (LFCR)

CIK 0001005286 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends May 25

For the year ended 2025-05-25, LIFECORE BIOMEDICAL, INC. DE reported revenue of $128.87M. Revenue grew 0.5% from the prior annual period.

Key ratios (year ended 2025-05-25)

31.3%
Gross margin
-13.4%
Operating margin
-30.0%
Net margin
-2898.0%
Return on year-end equity
0.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-Q · 2026-08-05

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.